A Cancer Conundrum: Too Many Drug Trials, Too Few Patients

Photo of A Cancer Conundrum: Too Many Drug Trials, Too Few Patients
Facebook
VKontakte
share_fav

Breakthroughs in immunotherapy and a rush to develop profitable new treatments have brought a crush of clinical trials scrambling for patients.

view The New York Times: Science
#immune system
#genetics and heredity
#clinical trials
#tumors
#drugs pharmaceuticals